Lamens Investments Africa Limited has been fined GH¢100,000.00 by the Food and Drugs Authority (FDA) for the violation of regulatory requirements in the handling of Moshosho Rice imported from India.
The FDA says the fine comes as a result of the company's re-bagging of about 22,000 bags of 50kg rice, which were imported from India but labelled as "Made in Ghana." The repacking of the products did not include vital information like manufacturing and expiration dates, which is in violation of the laws of Ghana.
In a statement issued by the FDA after its investigations, it said the company re-bagged the rice without approval from the Authority, a critical step required to ensure product integrity and compliance with safety standards.
The statement said the re-bagging operations were carried out in an unlicensed facility, and the company failed to ensure FDA supervision during the process. "The FDA imposed an administrative fine of GH¢100,000 on Lamens Investments Africa Limited for the following regulatory breaches: Re-bagging the rice without prior FDA approval, Conducting re-bagging operations in an unlicensed facility, and Failing to ensure FDA supervision during the re-bagging process," portions of the statement read.